The application of different doses of dexmedetomidine combined bupivacaine subarachnoid anesthesia in cesarean section.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-16008497

Enrollment

Unknown

Registered

2016-05-19

Start date

2016-05-31

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean section

Interventions

Dexmedetomidine:3µg

Dexmedetomidine:5µg

Dexmedetomidine:10µg

control:none

Eligibility

Sex/Gender

Female

Age

22 Years to 35 Years

Inclusion criteria

Inclusion criteria: Elective cesarean section in patients undergoing spinal anesthesia

Exclusion criteria

Exclusion criteria: Combined with serious heart and lung, liver and kidney disease, mental disorders, epilepsy and other medical history, patients with spinal anesthesia taboo

Design outcomes

Primary

Measure	Time frame
Sensory block plane;VAS;Ramsay;The incidence rate and degree of shivering;Apgar score;Umbilical cord blood PH;	—

Secondary

Measure	Time frame
Adverse events during operation;	—

Countries

China

Contacts

Public ContactYanzhuo Zhang

Department of Anesthesiology, the Second Affiliated Hospital of Harbin Medical University

zhangyanzhuo625@sina.com+86 18686856500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026